Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update

SAN DIEGO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced financial results for the second quarter ended June 30, 2018 and a business update. Dr. Dennis J. Carlo, President and Chie.....»»

SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -.....»»

AZEDRA® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA) AZEDRA U.S. Launch Progressing and AZEDRA Added.....»»

Pre-Commercial Launch Preparations Underway for AZEDRA® (iobenguane I 131) ahead of U.S. Food and Drug Administration (FDA) July 30th Action Date Top-Line Data from Phase 3 Trial .....»»

Completed the repayment in early Q3 2018 of the USD $8.5M gold linked credit fa.....»»

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmac.....»»

Positive Opinion on the Pediatric Investigation Plan from EMA for PEDMARKTM Targeting US approval of PEDMARKTM in the second half of 2019 Strong financial position with $24.5 million in cash and no .....»»

Reata Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results and an Update on Development Programs.....»»

RADNOR, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) ("Marinus" or "Company").....»»

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update.....»»

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Tech.....»»

InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018.....»»

CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results - China FDA (CFDA) import drug re.....»»

VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update PR Newswire ISNES, Belgium, Aug. 13, 2018 ISNES, Belgium, Aug. 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition") today announced financi.....»»

Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-am.....»»

Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results.....»»

WALTHAM, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage, specialty pharmac.....»»

Intercept Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update.....»»

In the release issued under the same headline on May 10, 2018 by Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), please note that in the Consolidated Balance Sheets table, Cash and cash equi.....»»